Kingdon Capital Management’s Biogen BIIB Stock Holding History

Kingdon Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,076	Closed	-$2.76M	–	109
2018 Q1	$2.76M	Buy	+10,076	New	+$3.13M	0.22%	87
2015 Q2	–	Sell	-5,100	Closed	-$2.15M	–	132
2015 Q1	$2.15M	Buy	+5,100	New	+$2.01M	0.09%	137

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Kingdon Capital Management's BIIB Position: Q2 2018 in Review

Kingdon Capital Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 10,076 shares — an estimated $2.76M sold.

Kingdon Capital Management first reported a position in BIIB in Q1 2015 and held it in 2 quarters. The position peaked at $2.76M in Q1 2018. 1,098 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Kingdon Capital Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Kingdon Capital Management sold 10,076 Biogen shares in Q2 2018, an estimated $2.76M.
Kingdon Capital Management first reported a position in Biogen in Q1 2015 and held it in 2 quarters.
Kingdon Capital Management's Biogen position peaked at $2.76M in Q1 2018.
1,098 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Kingdon Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.